Joby Aviation, Inc. filed a Form 8-K on September 10, 2026, disclosing a prospectus supplement covering the resale of 2,419,801 shares of common stock issued in connection with the acquisition of the passenger segment and operations of Strata Critical Medical, Inc. (f/k/a Blade Air Mobility, Inc.).
Key Highlights
- Shares covered: 2,419,801 shares of common stock, par value $0.0001 per share, are the subject of the prospectus supplement.
- Issuance basis: Shares were issued to a selling stockholder in connection with the achievement of certain EBITDA milestones by acquired operations during the 12-month period following the closing of the acquisition.
- Acquired entities: The acquisition covered the passenger segment and operations of Strata Critical Medical, Inc. (f/k/a Blade Air Mobility, Inc.), Trinity Medical Intermediate II, Inc., and Blade Urban Air Mobility, Inc.
- Registration Statement: The prospectus supplement forms part of the Company's Registration Statement on Form S-3 (No. 333-282809), originally filed October 24, 2024.
- Legal opinion: A legal opinion from Latham & Watkins LLP regarding the validity of the share issuance was filed as Exhibit 5.1.
- Signed by: Chief Financial Officer Rodrigo Brumana signed the filing on behalf of Joby Aviation, Inc.
Joby Aviation Registers Resale Shares Tied to Blade Acquisition Milestones
According to the filing, Joby Aviation, Inc. (NYSE:JOBY) filed a prospectus supplement on September 10, 2026, pursuant to Rule 424(b) under the Securities Act of 1933. The supplement relates to the resale of 2,419,801 shares of common stock that were previously issued by the company to a selling stockholder named in that supplement. The filing states that these shares were issued in connection with the achievement of certain EBITDA milestones by the acquired operations during the 12-month period following the closing of the acquisition.
The company disclosed that the acquisition involved the passenger segment and operations of three entities: Strata Critical Medical, Inc. (formerly known as Blade Air Mobility, Inc.), Trinity Medical Intermediate II, Inc., and Blade Urban Air Mobility, Inc. The prospectus supplement, the filing notes, forms a part of the Registration Statement on Form S-3 (No. 333-282809) that was originally filed with the U.S. Securities and Exchange Commission on October 24, 2024.
The filing also notes that Latham & Watkins LLP provided a legal opinion on the validity of the issuance of these shares of common stock, included as Exhibit 5.1. That opinion is incorporated by reference into the Registration Statement. No financial terms of the underlying acquisition or the specific EBITDA milestone thresholds were disclosed in this Current Report.
What Was Disclosed
Joby Aviation disclosed the filing of a prospectus supplement to register for resale 2,419,801 shares of common stock issued to a selling stockholder following achievement of EBITDA milestones tied to the acquisition of Blade-related operations. The supplement is part of an existing Form S-3 registration.




Please wait processing your request...